MedPath

Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial)

Completed
Conditions
Cardiovascular Prevention Behaviour
Registration Number
NCT04361877
Lead Sponsor
LMU Klinikum
Brief Summary

The study aims to determine the impact of COVID-19 pandemic lockdown on cardiovascular prevention behaviour.

Detailed Description

The COVID-19 pandemic resulted in a lockdown and social distancing in most countries all over the world. The impact of this national intervention on cardiovascular prevention behaviour (physical exercise, nutrition, smoking) is unknown. The COLA Trial aims to help clarifying these questions.

An online survey was distributed among bavarian students with standardized questions about physical activity, nutritional behavior, smoking and alcohol intake before and during lockdown.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1900
Inclusion Criteria

healthy adults over 18 years

Exclusion Criteria

any condition that does not allow physical activity

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of physical activity14 days

Questionnaire, 3 level scale ranging from less activity (Level 1), unchanged activity (Level 2), to increased activity (Level 3)

Secondary Outcome Measures
NameTimeMethod
step count6 days

wearables

change of stress level14 days

Questionnaire, 3 level scale ranging from lower stress level (Level 1), unchanged stress level (Level 2), to increased stress level (Level 3)

semiquantitative change of alcohol intake14 days

Questionnaire, 3 level scale ranging from less alcohol intake (Level 1), unchanged alcohol intake (Level 2), to increased alcohol intake (Level 3)

change of smoking behaviour14 days

Questionnaire, 3 level scale ranging from less smoking(Level 1), unchanged smoking (Level 2), to increased smoking (Level 3)

change of nutrition behaviour14 days

Questionnaire, 3 level scale ranging from less food intake (Level 1), unchanged food intake (Level 2), to increased food intake (Level 3)

Trial Locations

Locations (1)

University Hospital Munich (LMU Klinikum)

🇩🇪

Munich, Germany

© Copyright 2025. All Rights Reserved by MedPath